TYRO10 Peptide
€100.00
In stock
SKU
350493
Protein Family: Enzymes, Protein Kinases, Receptors and Channels
Pathway and Disease: Cell Motility, Signaling Molecules and Interaction
Alternate Names: Discoidin domain-containing receptor 2; Discoidin domain receptor 2; DDR2; Receptor protein-tyrosine kinase TKT; Tyrosine-protein kinase TYRO 10; Neurotrophic tyrosine kinase, receptor-related 3; CD167b antigen; NTRKR3
Accession No.: Q16832, NP_006173
Description:
TYRO10 (DDR2) is a tyrosine kinase receptor for fibrillar collagen that mediates fibroblast migration and proliferation. TYRO10 contributes to cutaneous wound healing.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 2036.2 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200131 is selected from a sequence within the center region of human TYRO10. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C92H126N22O29S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Pathway and Disease: Cell Motility, Signaling Molecules and Interaction
Alternate Names: Discoidin domain-containing receptor 2; Discoidin domain receptor 2; DDR2; Receptor protein-tyrosine kinase TKT; Tyrosine-protein kinase TYRO 10; Neurotrophic tyrosine kinase, receptor-related 3; CD167b antigen; NTRKR3
Accession No.: Q16832, NP_006173
Description:
TYRO10 (DDR2) is a tyrosine kinase receptor for fibrillar collagen that mediates fibroblast migration and proliferation. TYRO10 contributes to cutaneous wound healing.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 2036.2 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200131 is selected from a sequence within the center region of human TYRO10. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C92H126N22O29S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
| Is Featured? | No |
|---|
Write Your Own Review